Cargando…
Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model
Pancreatic cancer (PC) represents an intriguing topic for researchers. To date, the prognosis of metastasized PC is poor with just 7% of patients exceeding a five-year survival period. Thus, molecular modifications of existing drugs should be developed to change the course of the disease. Our previo...
Autores principales: | Conti, Giamaica, Pitea, Martina, Ossanna, Riccardo, Opri, Roberta, Tisci, Giada, Falvo, Elisabetta, Innamorati, Giulio, Ghanem, Esther, Sbarbati, Andrea, Ceci, Pierpaolo, Fracasso, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615572/ https://www.ncbi.nlm.nih.gov/pubmed/34829851 http://dx.doi.org/10.3390/biomedicines9111622 |
Ejemplares similares
-
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy
por: Falvo, Elisabetta, et al.
Publicado: (2020) -
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers
por: Fracasso, Giulio, et al.
Publicado: (2023) -
Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model
por: Damiani, Verena, et al.
Publicado: (2017) -
Multilineage-Differentiating Stress-Enduring Cells (Muse Cells): An Easily Accessible, Pluripotent Stem Cell Niche with Unique and Powerful Properties for Multiple Regenerative Medicine Applications
por: Ossanna, Riccardo, et al.
Publicado: (2023) -
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors
por: Falvo, Elisabetta, et al.
Publicado: (2021)